H.U. Group Holdings Inc
TSE:4544
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 190
2 822.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
H.U. Group Holdings Inc
H.U. Group Holdings Inc
Cost of Revenue
H.U. Group Holdings Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
H.U. Group Holdings Inc
TSE:4544
|
Cost of Revenue
-¥176B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
|
|
Solasto Corp
TSE:6197
|
Cost of Revenue
-¥114.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
BML Inc
TSE:4694
|
Cost of Revenue
-¥93.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-4%
|
|
|
V
|
Value HR Co Ltd
TSE:6078
|
Cost of Revenue
-¥5.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-16%
|
|
|
France Bed Holdings Co Ltd
TSE:7840
|
Cost of Revenue
-¥27.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
|
C
|
CUC Inc
TSE:9158
|
Cost of Revenue
-¥17.1B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
H.U. Group Holdings Inc
Glance View
H.U.Group Holdings, Inc. provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. The company is headquartered in Shinjuku, Tokyo-To and currently employs 5,897 full-time employees. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The firm operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
See Also
What is H.U. Group Holdings Inc's Cost of Revenue?
Cost of Revenue
-176B
JPY
Based on the financial report for Sep 30, 2024, H.U. Group Holdings Inc's Cost of Revenue amounts to -176B JPY.
What is H.U. Group Holdings Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-4%
Over the last year, the Cost of Revenue growth was -2%. The average annual Cost of Revenue growth rates for H.U. Group Holdings Inc have been -4% over the past three years , -7% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet
